Eli Lilly and Co (NYSE:LLY)

122.48
Delayed Data
As of Feb 15
 +1.73 / +1.43%
Today’s Change
74.51
Today|||52-Week Range
122.48
+5.84%
Year-to-Date
LLY Regular Dividend: LLY began trading ex-dividend on 02/14/19. A $0.645 dividend will be paid to shareholders of record as of 02/15/19.
Primecap Management Trims Eli Lilly Position
Feb 15 / GuruFocus News - Paid Partner Content
Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down
Feb 14 / Zacks.com - Paid Partner Content
Alkermes (ALKS) Q4 Earnings & Revenues Surpass Estimates
Feb 15 / Zacks.com - Paid Partner Content
Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report
Feb 13 / Zacks.com - Paid Partner Content
Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Ch...
Feb 15 / Zacks.com - Paid Partner Content
J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod
Feb 13 / Zacks.com - Paid Partner Content
Incyte (INCY) Q4 Earnings Miss Estimates, Revenues Beat
Feb 14 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Disney, Eli Lilly, U.S. Bancorp, Prudential and Al...
Feb 13 / Zacks.com - Paid Partner Content
5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings
Feb 14 / Zacks.com - Paid Partner Content
5 Tiny Biotech Stocks With Superb Growth Potential
Feb 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close120.75
Today’s open121.18
Day’s range120.40 - 122.48
Volume10,366,435
Average volume (3 months)5,421,615
Market cap$129.7B
Data as of 4:03pm ET, 02/15/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+0.77%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+7.36%
P/E ratio260.6
Price/Sales4.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+1.28+1.73%
SNYSanofi+0.99+2.38%
ABBVAbbVie+0.33+0.41%
AZNAstraZeneca+0.94+2.35%
Data as of 4:02pm ET, 02/15/2019

Financials

Next reporting dateApril 30, 2019
EPS forecast (this quarter)$1.37
Annual revenue (last year)$24.6B
Annual profit (last year)$3.2B
Net profit margin13.16%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Senior VP-Biotechnology &
Autoimmunity Research
Thomas F. Bumol
Corporate headquarters
Indianapolis, Indiana

Forecasts